Project Grant R21AR083090
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $249,000 Project Grant to the University of California, Irvine (UCI) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) on February 1, 2026, with a completion date of January 31, 2029. This research project aims to decode the repair and immunomodulatory functions of lymphatic vessels in wound healing by conducting two primary...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a $4.13M Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) effective September 1, 2025, through August 31, 2028. This research project addresses the significant public health challenge of acute and non-healing skin wounds, which affect over 100 million individuals annually with treatment...
- Federal Project Grant Award Summary This Project Grant, awarded July 15, 2025, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $169,344 in federal funding to the University of California, Davis through June 30, 2030. The award supports mechanistic research investigating systemic and local immunomodulation of fracture healing in polytrauma patients, addressing a...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant totaling $150,152 to the University of California, Los Angeles (UCLA) Office of Research Administration, effective March 27, 2026, through February 28, 2029. Under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), UCLA will conduct research characterizing migratory cell differentiation in developing zebrafish skin. The project...
- Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $224,100 Project Grant to the Regents of the University of California at Riverside on September 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This three-year research initiative, with completion targeted for August 31, 2028, focuses on identifying epigenetic factors that control epidermal stem cell longevity in adult skin....
- Federal Grant Award Summary Yale University received a $1.397 million Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded July 1, 2025, with completion targeted for April 30, 2030. The grant funds research to define the contributions of metabolic regulation of macrophages to skin wound healing, with specific focus on glutamine metabolism's role in...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $117,426 Project Grant to the University of California, San Diego, effective June 18, 2026, with completion by May 31, 2028. Under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), this award funds the development of a novel ultrashort echo time quantitative magnetization transfer (UTE-QMT) magnetic resonance imaging (MRI) method...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded New Jersey Institute of Technology a $330,107 Project Grant effective September 1, 2025, through June 30, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award supports fundamental research investigating the role of stress anisotropy—directional stress differences in extracellular matrices—in fibroblast activation and its...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $243,950 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 19, 2025, with a completion date of June 30, 2028. The research project deliverables include the development of machine learning-based prognostic models designed to predict which children...
- Federal Grant Award Summary Yale University received a $152,600 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded on November 16, 2026, with completion targeted for May 31, 2028. The research project, titled "Defining the Role of Catecholaminergic Neurons in Wound Healing," investigates how nerve endings within skin tissue contribute to the...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $368,156 to the University of California, Los Angeles on June 5, 2026, for research under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This two-year project, scheduled for completion by May 31, 2028, focuses on the development and optimization of UGiGel, an innovative gelatin-based, self-healing bioadhesive designed to address critical therapeutic gaps in chronic wound treatment. The primary deliverable is an advanced wound dressing product that overcomes limitations of existing commercial bioadhesives through a simplified one-step synthesis process utilizing a Ugi four-component reaction. The research aims to refine the initial UGiGel formulation to achieve improved skin-friendly detachability, enhanced antioxidant activity, and superior adhesion performance on wet tissue while demonstrating in vivo efficacy for chronic wounds arising from trauma, burns, surgeries, and conditions such as diabetes. This project addresses significant clinical needs in chronic wound repair by engineering a multifunctional bioadhesive with immunomodulatory properties that supports natural healing processes while reducing inflammation and infection risk. The research builds upon preliminary in vitro biocompatibility and adhesion data to develop a clinically viable therapeutic product that integrates multiple functions—physical protection, anti-inflammatory activity, and self-healing capability—into a single, cost-effective wound dressing platform.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $368.2k | 6/5/26 |